This activity is supported by educational grants from AbbVie, Allergan Inc.,
Dova Pharmaceuticals, Gilead, Intercept Pharmaceuticals, Inc.,
Mallinckrodt Pharmaceuticals, and Salix Pharmaceuticals.

Jointly provided by the Annenberg Center for Health Sciences 
at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.

  • Facebook Social Icon
  • Twitter Social Icon

© 2020 GI and Liver Association of the Americas

AGENDA

FRIDAY, AUGUST 21, 2020

12:00 – 12:50 PM

Lunch

12:50 – 1:00 PM

Welcome / Introduction

SESSION I (Nancy Reau, MD)

1:00 – 1:30 PM

Hepatitis C: Expanding Indications, Black Box Warnings and Screening

Nancy Reau, MD

1:30 – 2:00 PM

ASH vs. NASH: Similarities and Differences

Craig McClain, MD

2:00 – 2:45 PM

Complications of Portal Hypertension: Management Options for Hepatic Encephalopathy, Thrombocytopenia, Varices, and Hepatorenal Syndrome

Mack Mitchell, MD and Santiago Munoz, MD

2:45 – 3:15 PM

Q&A / Panel Discussion

3:15 – 3:30 PM

Break

SESSION II (Lawrence Schiller, MD)

3:30 – 4:00 PM

Practical Management of Clostridioides Difficile: Not so Difficile? 

Lawrence Schiller, MD

4:00 – 4:25 PM

Microbiome Based Treatments for IBS: Food, Bugs, or Drugs

TBD

4:25 – 4:50 PM

Management of Diverticulitis

Brennan Spiegel, MD

4:50 – 5:15 PM

Q&A / Panel Discussion

5:15 – 5:30 PM

Day 1 Wrap-up

5:30 – 7:00 PM

Welcome Reception

SATURDAY, AUGUST 22, 2020

7:30 – 8:20 AM

Breakfast

8:20 – 8:30 AM

Welcome

SESSION III (Michael Vaezi, MD)

8:30 – 9:00 AM

How Opioid Use Might Impact Esophageal Symptoms and Motility 

Michael Vaezi, MD

9:00 – 9:30 AM

GERD and Sleep: An Eye-opening Experience

Ronnie Fass, MD

9:30 – 10:00 AM

Pancreatic Cysts and the Risk for Pancreatic Cancer

TBD

10:00 – 10:30 AM

Q&A / Panel Discussion

10:30 – 10:45 AM

Break

10:45 – 11:45 AM

Parallel Sessions

(Attendees select one of the following)

  • Inflammatory Bowel Disease (IBD)

  • GI Woes from Head to Toe (Non-IBD)

  • Viral Hepatitis, Cholestatic Disease and Complications of Cirrhosis

  • Alcoholic and Non-Alcoholic Fatty Liver Disease

12:00 PM – 12:50 PM

Lunch

SESSION IV (Gary Lichtenstein, MD)

1:00 – 1:25 PM

Practical Applications of Treat to Target in Inflammatory Bowel Disease (IBD)

Gary Lichtenstein, MD

1:25 – 1:50 PM

Managing Post-operative Crohn's Disease

TBD

1:50 – 2:15 PM

Health Care Maintenance in IBD

Francis Farraye, MD

2:15 – 2:40 PM

Managing Fertility and Pregnancy in IBD

Anita Afzali, MD

2:40 – 3:05 PM

Q&A / Panel Discussion

3:05 – 3:20 PM

Break

SESSION V (Hashem El-Serag, MD)

3:20 – 3:50 PM

Primary Biliary Cholangitis (PBC): Diagnosis and Treatment

TBD

3:50 – 4:20 PM

Hepatocellular Carcinoma: Diagnosis and Treatment

Hashem El-Serag, MD

4:20 – 4:40 PM

Q&A / Panel Discussion

4:40 – 4:45 PM

Closing Remarks